AI Article Synopsis
- - The hinotori™ Surgical Robot System received pharmaceutical approval in Japan for colorectal cancer surgery in October 2022 and features advanced capabilities like an eight-axis operating arm and a flexible viewer.
- - A 55-year-old male patient diagnosed with stage IIA rectal cancer underwent successful surgery utilizing this robotic system, which allowed for optimal maneuvering and adjustments during the procedure.
- - This case marks the first instance of rectal cancer surgery performed globally using the hinotori™ system with a transanal and total mesorectal excision (TaTME) technique by two surgical teams.
Article Abstract
In Japan, the hinotori™ Surgical Robot System obtained pharmaceutical approval for use in colorectal cancer surgery in October 2022. This system has an operating arm with eight axes, adjustable arm base, and flexible three-dimensional viewer, which are expected to be advantageous in colorectal cancer surgery. A 55-year-old man presented to our hospital with melena and was diagnosed with cStage IIA (cT3N0M0) rectal cancer. The patient underwent intersphincteric resection using hinotori™ Surgical Robot System. Appropriate port placement was available for rectal manipulation, lymph node dissection, and arm base angle adjustment. Herein, we report the world's first rectal cancer surgery using the hinotori™ Surgical Robot System with TaTME by two teams.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286364 | PMC |
| http://dx.doi.org/10.23922/jarc.2023-045 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!